论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
hsa_circ_0008450 的沉默通过调控 microRNA-214-3p/EZH2 轴抑制肝癌的进展
Authors Lin T, Dai Y, Guo X, Chen W, Zhao J, Cao L, Wu Z
Received 10 July 2019
Accepted for publication 9 October 2019
Published 24 October 2019 Volume 2019:11 Pages 9133—9143
DOI https://doi.org/10.2147/CMAR.S222716
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Melinda Thomas
Peer reviewer comments 3
Editor who approved publication: Dr Beicheng Sun
Purpose: Circular RNA (circRNA) hsa_circ_0008450 has been shown to be up-regulated in hepatocellular carcinoma (HCC). However, the functional role of hsa_circ_0008450 and its molecular mechanism are still unknown.
Patients and methods: We used qRT-PCR and Western blot to examine the expression levels of hsa_circ_0008450, microRNA-214-3p (miR-214-3p), and enhancer of zeste homolog 2 (EZH2) protein. CCK8 assay and wound healing assay were used to detect cell viability and cell migration capability. Cell apoptosis was assessed by flow cytometry. Luciferase reporter assay was used to explore the interaction among hsa_circ_0008450, miR-214-3p, and EZH2.
Results: hsa_circ_0008450 was significantly increased in HCC tissues and cells. Furthermore, knockdown of hsa_circ_0008450 in HCC cells inhibited cell proliferation, invasion, and migration. Mechanically, hsa_circ_0008450 promoted the expression of EZH2 protein through sponging miR-214-3p. Knockdown of circ_0008450 suppressed tumorigenesis of HCC cells in vivo.
Conclusion: Knockdown of hsa_circ_0008450 inhibits HCC progression by regulating miR-214-3p/EZH2 axis. This study suggests that hsa_circ_0008450 may serve as a novel target for the treatment of HCC.
Keywords: circular RNAs, hepatocellular carcinoma, hsa_circ_0008450, miR-214-3p, enhancer of zeste homolog 2
